- Home
- BV vs IRON Comparison
BV vs IRON Comparison
Compare BV & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BV
- IRON
- Stock Information
- Founded
- BV 1939
- IRON 2017
- Country
- BV United States
- IRON United States
- Employees
- BV N/A
- IRON N/A
- Industry
- BV Business Services
- IRON Biotechnology: Pharmaceutical Preparations
- Sector
- BV Consumer Discretionary
- IRON Health Care
- Exchange
- BV Nasdaq
- IRON Nasdaq
- Market Cap
- BV 1.3B
- IRON 1.4B
- IPO Year
- BV 2018
- IRON N/A
- Fundamental
- Price
- BV $15.81
- IRON $44.24
- Analyst Decision
- BV Buy
- IRON Strong Buy
- Analyst Count
- BV 8
- IRON 10
- Target Price
- BV $17.41
- IRON $83.80
- AVG Volume (30 Days)
- BV 618.1K
- IRON 397.9K
- Earning Date
- BV 05-07-2025
- IRON 05-07-2025
- Dividend Yield
- BV N/A
- IRON N/A
- EPS Growth
- BV N/A
- IRON N/A
- EPS
- BV N/A
- IRON N/A
- Revenue
- BV $2,729,300,000.00
- IRON N/A
- Revenue This Year
- BV $3.29
- IRON N/A
- Revenue Next Year
- BV $3.67
- IRON N/A
- P/E Ratio
- BV N/A
- IRON N/A
- Revenue Growth
- BV N/A
- IRON N/A
- 52 Week Low
- BV $11.24
- IRON $28.25
- 52 Week High
- BV $18.89
- IRON $68.73
- Technical
- Relative Strength Index (RSI)
- BV 76.12
- IRON 45.99
- Support Level
- BV $14.11
- IRON $40.36
- Resistance Level
- BV $16.61
- IRON $47.21
- Average True Range (ATR)
- BV 0.45
- IRON 2.87
- MACD
- BV 0.22
- IRON 0.10
- Stochastic Oscillator
- BV 77.64
- IRON 37.67
About BV BrightView Holdings Inc.
BrightView Holdings Inc is a provider of commercial landscaping services in the United States. The company provides commercial landscaping services, landscape maintenance, and enhancements to tree care and landscape development. It operates through two segments namely Maintenance Services, and Development Services. The Maintenance Services are self-performed through a national branch network and are route-based in nature. It includes mowing, gardening, mulching and snow removal, water management etc. And Development Services are comprised of sophisticated design, coordination, and installation of landscapes at recognizable corporate, athletic, and university complexes. The company generates a majority of its revenue from Maintenance Services.
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.